Andrea G. Hohmann - Publications

Affiliations: 
Psychological & Brain Sciences Indiana University, Bloomington, Bloomington, IN, United States 
Area:
cannabinoid pharmacology
Website:
http://www.indiana.edu/~alldrp/members/hohmann.html

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Li AL, Lin X, Dhopeshwarkar AS, Thomaz AC, Carey LM, Liu Y, Nikas SP, Makriyannis A, Mackie K, Hohmann AG. The cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal. Molecular Pharmacology. PMID 30504240 DOI: 10.1124/mol.118.113233  0.72
2018 Slivicki RA, Saberi SA, Iyer V, Vemuri K, Makriyannis A, Hohmann AG. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit. The Journal of Pharmacology and Experimental Therapeutics. PMID 30275151 DOI: 10.1124/jpet.118.252288  0.72
2018 Liu Y, Ji L, Eno M, Kudalkar S, Li A, Schimpgen M, Benchama O, Morales P, Xu S, Hurst DP, Wu S, Mohammad KA, Wood JT, Zvonok N, Papahatjis D, ... ... Hohmann A, et al. (R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes. Journal of Medicinal Chemistry. PMID 30196704 DOI: 10.1021/acs.jmedchem.8b00611  0.72
2017 Slivicki RA, Xu Z, Kulkarni PM, Pertwee RG, Mackie K, Thakur GA, Hohmann AG. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence. Biological Psychiatry. PMID 28823711 DOI: 10.1016/j.biopsych.2017.06.032  0.32
2017 Carey LM, Gutierrez T, Deng L, Lee WH, Mackie K, Hohmann AG. Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice. Scientific Reports. 7: 944. PMID 28428628 DOI: 10.1038/s41598-017-01062-2  0.4
2017 Carey LM, Lee WH, Gutierrez T, Kulkarni PM, Thakur GA, Lai YY, Hohmann AG. Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats. Neuroscience. PMID 28285942 DOI: 10.1016/j.neuroscience.2017.02.055  0.4
2016 Deng L, Lee WH, Xu Z, Makriyannis A, Hohmann AG. Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems. Pharmacological Research. PMID 27773824 DOI: 10.1016/j.phrs.2016.10.007  0.72
2016 Smith AE, Xu Z, Lai YY, Kulkarni PM, Thakur GA, Hohmann AG, Crystal JD. Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors. Behavioural Brain Research. PMID 26909849 DOI: 10.1016/j.bbr.2016.02.021  1
2015 Lee WH, Xu Z, Ashpole NM, Hudmon A, Kulkarni PM, Thakur GA, Lai YY, Hohmann AG. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics. Neuropharmacology. PMID 26071110 DOI: 10.1016/j.neuropharm.2015.05.038  1
2015 Marcus DJ, Zee M, Hughes A, Yuill MB, Hohmann AG, Mackie K, Guindon J, Morgan DJ. Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase. Molecular Pain. 11: 34. PMID 26065412 DOI: 10.1186/s12990-015-0031-4  1
2015 Deng L, Cornett BL, Mackie K, Hohmann AG. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain. Molecular Pharmacology. 88: 64-74. PMID 25904556 DOI: 10.1124/mol.115.098483  1
2015 Deng L, Guindon J, Cornett BL, Makriyannis A, Mackie K, Hohmann AG. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Biological Psychiatry. 77: 475-87. PMID 24853387 DOI: 10.1016/j.biopsych.2014.04.009  1
2014 Piomelli D, Hohmann AG, Seybold V, Hammock BD. A lipid gate for the peripheral control of pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 15184-91. PMID 25392487 DOI: 10.1523/JNEUROSCI.3475-14.2014  1
2014 Guindon J, Deng L, Fan B, Wager-Miller J, Hohmann AG. Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status. Molecular Pain. 10: 56. PMID 25189223 DOI: 10.1186/1744-8069-10-56  1
2014 Rahn EJ, Deng L, Thakur GA, Vemuri K, Zvonok AM, Lai YY, Makriyannis A, Hohmann AG. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery. Molecular Pain. 10: 27. PMID 24742127 DOI: 10.1186/1744-8069-10-27  1
2014 Lynch ME, Cesar-Rittenberg P, Hohmann AG. A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. Journal of Pain and Symptom Management. 47: 166-73. PMID 23742737 DOI: 10.1016/j.jpainsymman.2013.02.018  1
2013 Guindon J, Hohmann AG. Use of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatin. Neuroscience Letters. 544: 41-6. PMID 23570729 DOI: 10.1016/j.neulet.2013.03.033  1
2013 Crystal JD, Alford WT, Zhou W, Hohmann AG. Source memory in the rat. Current Biology : Cb. 23: 387-91. PMID 23394830 DOI: 10.1016/j.cub.2013.01.023  1
2013 Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 67: 94-109. PMID 23127915 DOI: 10.1016/j.phrs.2012.10.013  1
2012 Deng L, Guindon J, Vemuri VK, Thakur GA, White FA, Makriyannis A, Hohmann AG. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CBâ‚‚ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy. Molecular Pain. 8: 71. PMID 22998838 DOI: 10.1186/1744-8069-8-71  1
2012 Gregg LC, Jung KM, Spradley JM, Nyilas R, Suplita RL, Zimmer A, Watanabe M, Mackie K, Katona I, Piomelli D, Hohmann AG. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9457-68. PMID 22787031 DOI: 10.1523/JNEUROSCI.0013-12.2012  1
2012 Zhou W, Hohmann AG, Crystal JD. Rats answer an unexpected question after incidental encoding. Current Biology : Cb. 22: 1149-53. PMID 22633809 DOI: 10.1016/j.cub.2012.04.040  1
2011 Sciolino NR, Zhou W, Hohmann AG. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 64: 226-34. PMID 21600985 DOI: 10.1016/j.phrs.2011.04.010  1
2011 Gutierrez T, Crystal JD, Zvonok AM, Makriyannis A, Hohmann AG. Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain. Pain. 152: 1976-87. PMID 21550725 DOI: 10.1016/j.pain.2011.03.038  1
2011 Guindon J, Hohmann AG. The endocannabinoid system and cancer: therapeutic implication. British Journal of Pharmacology. 163: 1447-63. PMID 21410463 DOI: 10.1111/j.1476-5381.2011.01327.x  1
2011 Rahn EJ, Thakur GA, Wood JA, Zvonok AM, Makriyannis A, Hohmann AG. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects. Pharmacology, Biochemistry, and Behavior. 98: 493-502. PMID 21382397 DOI: 10.1016/j.pbb.2011.02.024  1
2011 Guindon J, Guijarro A, Piomelli D, Hohmann AG. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. British Journal of Pharmacology. 163: 1464-78. PMID 21198549 DOI: 10.1111/j.1476-5381.2010.01192.x  1
2011 Gutierrez T, Hohmann AG. Cannabinoids for the treatment of neuropathic pain: Are they safe and effective? Future Neurology. 6: 129-133. DOI: 10.2217/fnl.11.6  1
2010 Clapper JR, Moreno-Sanz G, Russo R, Guijarro A, Vacondio F, Duranti A, Tontini A, Sanchini S, Sciolino NR, Spradley JM, Hohmann AG, Calignano A, Mor M, Tarzia G, Piomelli D. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nature Neuroscience. 13: 1265-70. PMID 20852626 DOI: 10.1038/nn.2632  1
2010 Spradley JM, Guindon J, Hohmann AG. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 62: 249-58. PMID 20416378 DOI: 10.1016/j.phrs.2010.03.007  1
2010 Sciolino NR, Bortolato M, Eisenstein SA, Fu J, Oveisi F, Hohmann AG, Piomelli D. Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. Neuroscience. 168: 371-86. PMID 20394803 DOI: 10.1016/j.neuroscience.2010.04.007  1
2010 Rahn EJ, Zvonok AM, Makriyannis A, Hohmann AG. Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation. The Aaps Journal. 12: 147-57. PMID 20127295 DOI: 10.1208/s12248-009-9170-8  1
2010 Eisenstein SA, Clapper JR, Holmes PV, Piomelli D, Hohmann AG. A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 61: 419-29. PMID 20044005 DOI: 10.1016/j.phrs.2009.12.013  1
2009 Guindon J, Hohmann AG. The endocannabinoid system and pain. Cns & Neurological Disorders Drug Targets. 8: 403-21. PMID 19839937 DOI: 10.2174/187152709789824660  1
2009 Rahn EJ, Hohmann AG. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 713-37. PMID 19789075 DOI: 10.1016/j.nurt.2009.08.002  1
2009 Eisenstein SA, Holmes PV, Hohmann AG. Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation. Synapse (New York, N.Y.). 63: 941-50. PMID 19593824 DOI: 10.1002/syn.20679  1
2009 Nyilas R, Gregg LC, Mackie K, Watanabe M, Zimmer A, Hohmann AG, Katona I. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. The European Journal of Neuroscience. 29: 1964-78. PMID 19453631 DOI: 10.1111/j.1460-9568.2009.06751.x  1
2009 Anand P, Whiteside G, Fowler CJ, Hohmann AG. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Research Reviews. 60: 255-66. PMID 19150370 DOI: 10.1016/j.brainresrev.2008.12.003  1
2008 Rahn EJ, Zvonok AM, Thakur GA, Khanolkar AD, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. The Journal of Pharmacology and Experimental Therapeutics. 327: 584-91. PMID 18664590 DOI: 10.1124/jpet.108.141994  1
2008 Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters. Psychopharmacology. 200: 333-46. PMID 18545985 DOI: 10.1007/s00213-008-1209-5  1
2008 Guindon J, Hohmann AG. A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. British Journal of Pharmacology. 153: 1341-3. PMID 18297102 DOI: 10.1038/bjp.2008.41  1
2008 Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. British Journal of Pharmacology. 153: 319-34. PMID 17994113 DOI: 10.1038/sj.bjp.0707531  1
2008 Suplita RL, Eisenstein SA, Neely MH, Moise AM, Hohmann AG. Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia. Neuropharmacology. 54: 161-71. PMID 17714742 DOI: 10.1016/j.neuropharm.2007.07.006  1
2007 Rahn EJ, Makriyannis A, Hohmann AG. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. British Journal of Pharmacology. 152: 765-77. PMID 17572696 DOI: 10.1038/sj.bjp.0707333  1
2007 Hohmann AG. Inhibitors of monoacylglycerol lipase as novel analgesics. British Journal of Pharmacology. 150: 673-5. PMID 17293886 DOI: 10.1038/sj.bjp.0707153  1
2007 Gutierrez T, Farthing JN, Zvonok AM, Makriyannis A, Hohmann AG. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. British Journal of Pharmacology. 150: 153-63. PMID 17160008 DOI: 10.1038/sj.bjp.0706984  1
2006 Hohmann AG, Suplita RL. Endocannabinoid mechanisms of pain modulation. The Aaps Journal. 8: E693-708. PMID 17233533 DOI: 10.1208/aapsj080479  1
2006 LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. The Journal of Pharmacology and Experimental Therapeutics. 319: 1051-61. PMID 16997973 DOI: 10.1124/jpet.106.111385  1
2006 Hohmann AG. Localization of cannabinoid CB1 receptor mRNA using ribonucleotide probes: methods for double- and single-label in situ hybridization. Methods in Molecular Medicine. 123: 71-89. PMID 16506402  1
2006 Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neuroscience Letters. 397: 180-4. PMID 16378681 DOI: 10.1016/j.neulet.2005.12.008  1
2006 Suplita RL, Gutierrez T, Fegley D, Piomelli D, Hohmann AG. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. Neuropharmacology. 50: 372-9. PMID 16316669 DOI: 10.1016/j.neuropharm.2005.10.007  1
2005 Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handbook of Experimental Pharmacology. 509-54. PMID 16596786 DOI: 10.1007/3-540-26573-2-17  1
2005 Hohmann AG, Neely MH, Piña J, Nackley AG. Neonatal chronic hind paw inflammation alters sensitization to intradermal capsaicin in adult rats: a behavioral and immunocytochemical study. The Journal of Pain : Official Journal of the American Pain Society. 6: 798-808. PMID 16326368 DOI: 10.1016/j.jpain.2005.07.009  1
2005 Hohmann AG. A cannabinoid pharmacotherapy for chemotherapy-evoked painful peripheral neuropathy. Pain. 118: 3-5. PMID 16203094 DOI: 10.1016/j.pain.2005.07.007  1
2005 Suplita RL, Farthing JN, Gutierrez T, Hohmann AG. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology. 49: 1201-9. PMID 16129456 DOI: 10.1016/j.neuropharm.2005.07.007  1
2005 Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature. 435: 1108-12. PMID 15973410 DOI: 10.1038/nature03658  1
2004 Nackley AG, Zvonok AM, Makriyannis A, Hohmann AG. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. Journal of Neurophysiology. 92: 3562-74. PMID 15317842 DOI: 10.1152/jn.00886.2003  1
2004 Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. The Journal of Pharmacology and Experimental Therapeutics. 308: 446-53. PMID 14610224 DOI: 10.1124/jpet.103.060079  1
2003 Gutierrez T, Nackley AG, Neely MH, Freeman KG, Edwards GL, Hohmann AG. Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception. Brain Research. 987: 176-85. PMID 14499961 DOI: 10.1016/S0006-8993(03)03324-9  1
2003 Crystal JD, Maxwell KW, Hohmann AG. Cannabinoid modulation of sensitivity to time. Behavioural Brain Research. 144: 57-66. PMID 12946595 DOI: 10.1016/S0166-4328(03)00062-7  1
2003 Nackley AG, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience. 119: 747-57. PMID 12809695 DOI: 10.1016/S0306-4522(03)00126-X  1
2003 Nackley AG, Suplita RL, Hohmann AG. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience. 117: 659-70. PMID 12617970 DOI: 10.1016/S0306-4522(02)00870-9  1
2002 Hohmann AG. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chemistry and Physics of Lipids. 121: 173-90. PMID 12505699 DOI: 10.1016/S0009-3084(02)00154-8  1
2000 Ruda MA, Ling QD, Hohmann AG, Peng YB, Tachibana T. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science (New York, N.Y.). 289: 628-31. PMID 10915627 DOI: 10.1126/science.289.5479.628  1
2000 Hohmann AG, Herkenham M. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse (New York, N.Y.). 37: 71-80. PMID 10842353 DOI: 10.1002/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K  1
1999 Hohmann AG, Tsou K, Walker JM. Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine. Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica. 20: 1132-6. PMID 11216448  1
1999 Walker JM, Hohmann AG, Martin WJ, Strangman NM, Huang SM, Tsou K. The neurobiology of cannabinoid analgesia. Life Sciences. 65: 665-73. PMID 10462067 DOI: 10.1016/S0024-3205(99)00289-1  1
1999 Hohmann AG, Herkenham M. Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience. 92: 1171-5. PMID 10426476 DOI: 10.1016/S0306-4522(99)00220-1  1
1999 Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 5780-5. PMID 10318961 DOI: 10.1073/pnas.96.10.5780  1
1999 Hohmann AG, Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience. 90: 923-31. PMID 10218792 DOI: 10.1016/S0306-4522(98)00524-7  1
1999 Hohmann AG, Briley EM, Herkenham M. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Research. 822: 17-25. PMID 10082879 DOI: 10.1016/S0006-8993(98)01321-3  1
1999 Hohmann AG, Tsou K, Walker JM. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. Journal of Neurophysiology. 81: 575-83. PMID 10036261  1
1998 Hohmann AG, Tsou K, Walker JM. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neuroscience Letters. 257: 119-22. PMID 9870334 DOI: 10.1016/S0304-3940(98)00802-7  1
1998 Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Research. 813: 323-8. PMID 9838180 DOI: 10.1016/S0006-8993(98)01031-2  1
1998 Hohmann AG, Herkenham M. Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment. Neuroscience Letters. 252: 13-6. PMID 9756347 DOI: 10.1016/S0304-3940(98)00534-5  1
1996 Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM. Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience. 70: 791-8. PMID 10627219  1
1996 Martin WJ, Hohmann AG, Walker JM. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6601-11. PMID 8815936  1
1995 Hohmann AG, Martin WJ, Tsou K, Walker JM. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sciences. 56: 2111-8. PMID 7776839 DOI: 10.1016/0024-3205(95)00196-D  1
1994 Leitner ML, Hohmann AG, Patrick SL, Walker JM. Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain. European Journal of Pharmacology. 259: 65-9. PMID 7957595 DOI: 10.1016/0014-2999(94)90158-9  1
1994 Hohmann AG, Clement RW, Walker JM. Changes in regional glucose metabolism and behavior following intranigral application of the kappa opiate agonist U50,488 Regulatory Peptides. 53: S257-S258. DOI: 10.1016/0167-0115(94)90337-9  1
1992 Hohmann AG, Matsumoto RR, Hemstreet MK, Patrick SL, Margulies JE, Hammer RP, Walker JM. Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain. Brain Research. 593: 265-73. PMID 1450934 DOI: 10.1016/0006-8993(92)91317-8  1
1992 Walker JM, Bowen WD, Goldstein SR, Roberts AH, Patrick SL, Hohmann AG, DeCosta B. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Brain Research. 581: 33-8. PMID 1323368 DOI: 10.1016/0006-8993(92)90340-F  1
1990 Thompson LA, Matsumoto RR, Hohmann AG, Walker JM. Striatonigral prodynorphin: a model system for understanding opioid peptide function. Annals of the New York Academy of Sciences. 579: 192-203. PMID 2159742 DOI: 10.1111/j.1749-6632.1990.tb48361.x  1
Show low-probability matches.